Machinery and methods in freeze-drying
The author assumes familiarity with literature on the freeze-drying of biologicals to which he provides a critical supplement. Freeze-drying should be conceived as part of a total system and in terms of the end product. This product is not an end in itself, and must satisfy clinical and commercial r...
Ausführliche Beschreibung
Autor*in: |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
1971 |
---|
Reproduktion: |
Elsevier Journal Backfiles on ScienceDirect 1907 - 2002 |
---|---|
Übergeordnetes Werk: |
in: Cryobiology - Amsterdam : Elsevier, 8(1971), 2, Seite 153-172 |
Übergeordnetes Werk: |
volume:8 ; year:1971 ; number:2 ; pages:153-172 |
Links: |
---|
Katalog-ID: |
NLEJ183053796 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLEJ183053796 | ||
003 | DE-627 | ||
005 | 20210706192703.0 | ||
007 | cr uuu---uuuuu | ||
008 | 070505s1971 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)NLEJ183053796 | ||
035 | |a (DE-599)GBVNLZ183053796 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
245 | 1 | 0 | |a Machinery and methods in freeze-drying |
264 | 1 | |c 1971 | |
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a The author assumes familiarity with literature on the freeze-drying of biologicals to which he provides a critical supplement. Freeze-drying should be conceived as part of a total system and in terms of the end product. This product is not an end in itself, and must satisfy clinical and commercial requirements which can be optimized, if at all, with difficulty.The more significant components of a total system, from formulation of the preparation to be freeze-dried and the choice of containers, to prefreezing and the layout and control of the freeze-drying system, are briefly reviewed against the need for a product which is therapeutically satisfactory and free from contamination by microorganisms and submicron particles. Mention is also made of a few special systems. | ||
533 | |f Elsevier Journal Backfiles on ScienceDirect 1907 - 2002 | ||
700 | 1 | |a Rowe, T.W.G. |4 oth | |
773 | 0 | 8 | |i in |t Cryobiology |d Amsterdam : Elsevier |g 8(1971), 2, Seite 153-172 |w (DE-627)NLEJ176926798 |w (DE-600)1463192-1 |x 0011-2240 |7 nnns |
773 | 1 | 8 | |g volume:8 |g year:1971 |g number:2 |g pages:153-172 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/0011-2240(71)90023-X |
912 | |a GBV_USEFLAG_H | ||
912 | |a ZDB-1-SDJ | ||
912 | |a GBV_NL_ARTICLE | ||
951 | |a AR | ||
952 | |d 8 |j 1971 |e 2 |h 153-172 |
matchkey_str |
article:00112240:1971----::ahnradehdife |
---|---|
hierarchy_sort_str |
1971 |
publishDate |
1971 |
allfields |
(DE-627)NLEJ183053796 (DE-599)GBVNLZ183053796 DE-627 ger DE-627 rakwb eng Machinery and methods in freeze-drying 1971 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The author assumes familiarity with literature on the freeze-drying of biologicals to which he provides a critical supplement. Freeze-drying should be conceived as part of a total system and in terms of the end product. This product is not an end in itself, and must satisfy clinical and commercial requirements which can be optimized, if at all, with difficulty.The more significant components of a total system, from formulation of the preparation to be freeze-dried and the choice of containers, to prefreezing and the layout and control of the freeze-drying system, are briefly reviewed against the need for a product which is therapeutically satisfactory and free from contamination by microorganisms and submicron particles. Mention is also made of a few special systems. Elsevier Journal Backfiles on ScienceDirect 1907 - 2002 Rowe, T.W.G. oth in Cryobiology Amsterdam : Elsevier 8(1971), 2, Seite 153-172 (DE-627)NLEJ176926798 (DE-600)1463192-1 0011-2240 nnns volume:8 year:1971 number:2 pages:153-172 http://dx.doi.org/10.1016/0011-2240(71)90023-X GBV_USEFLAG_H ZDB-1-SDJ GBV_NL_ARTICLE AR 8 1971 2 153-172 |
spelling |
(DE-627)NLEJ183053796 (DE-599)GBVNLZ183053796 DE-627 ger DE-627 rakwb eng Machinery and methods in freeze-drying 1971 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The author assumes familiarity with literature on the freeze-drying of biologicals to which he provides a critical supplement. Freeze-drying should be conceived as part of a total system and in terms of the end product. This product is not an end in itself, and must satisfy clinical and commercial requirements which can be optimized, if at all, with difficulty.The more significant components of a total system, from formulation of the preparation to be freeze-dried and the choice of containers, to prefreezing and the layout and control of the freeze-drying system, are briefly reviewed against the need for a product which is therapeutically satisfactory and free from contamination by microorganisms and submicron particles. Mention is also made of a few special systems. Elsevier Journal Backfiles on ScienceDirect 1907 - 2002 Rowe, T.W.G. oth in Cryobiology Amsterdam : Elsevier 8(1971), 2, Seite 153-172 (DE-627)NLEJ176926798 (DE-600)1463192-1 0011-2240 nnns volume:8 year:1971 number:2 pages:153-172 http://dx.doi.org/10.1016/0011-2240(71)90023-X GBV_USEFLAG_H ZDB-1-SDJ GBV_NL_ARTICLE AR 8 1971 2 153-172 |
allfields_unstemmed |
(DE-627)NLEJ183053796 (DE-599)GBVNLZ183053796 DE-627 ger DE-627 rakwb eng Machinery and methods in freeze-drying 1971 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The author assumes familiarity with literature on the freeze-drying of biologicals to which he provides a critical supplement. Freeze-drying should be conceived as part of a total system and in terms of the end product. This product is not an end in itself, and must satisfy clinical and commercial requirements which can be optimized, if at all, with difficulty.The more significant components of a total system, from formulation of the preparation to be freeze-dried and the choice of containers, to prefreezing and the layout and control of the freeze-drying system, are briefly reviewed against the need for a product which is therapeutically satisfactory and free from contamination by microorganisms and submicron particles. Mention is also made of a few special systems. Elsevier Journal Backfiles on ScienceDirect 1907 - 2002 Rowe, T.W.G. oth in Cryobiology Amsterdam : Elsevier 8(1971), 2, Seite 153-172 (DE-627)NLEJ176926798 (DE-600)1463192-1 0011-2240 nnns volume:8 year:1971 number:2 pages:153-172 http://dx.doi.org/10.1016/0011-2240(71)90023-X GBV_USEFLAG_H ZDB-1-SDJ GBV_NL_ARTICLE AR 8 1971 2 153-172 |
allfieldsGer |
(DE-627)NLEJ183053796 (DE-599)GBVNLZ183053796 DE-627 ger DE-627 rakwb eng Machinery and methods in freeze-drying 1971 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The author assumes familiarity with literature on the freeze-drying of biologicals to which he provides a critical supplement. Freeze-drying should be conceived as part of a total system and in terms of the end product. This product is not an end in itself, and must satisfy clinical and commercial requirements which can be optimized, if at all, with difficulty.The more significant components of a total system, from formulation of the preparation to be freeze-dried and the choice of containers, to prefreezing and the layout and control of the freeze-drying system, are briefly reviewed against the need for a product which is therapeutically satisfactory and free from contamination by microorganisms and submicron particles. Mention is also made of a few special systems. Elsevier Journal Backfiles on ScienceDirect 1907 - 2002 Rowe, T.W.G. oth in Cryobiology Amsterdam : Elsevier 8(1971), 2, Seite 153-172 (DE-627)NLEJ176926798 (DE-600)1463192-1 0011-2240 nnns volume:8 year:1971 number:2 pages:153-172 http://dx.doi.org/10.1016/0011-2240(71)90023-X GBV_USEFLAG_H ZDB-1-SDJ GBV_NL_ARTICLE AR 8 1971 2 153-172 |
allfieldsSound |
(DE-627)NLEJ183053796 (DE-599)GBVNLZ183053796 DE-627 ger DE-627 rakwb eng Machinery and methods in freeze-drying 1971 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The author assumes familiarity with literature on the freeze-drying of biologicals to which he provides a critical supplement. Freeze-drying should be conceived as part of a total system and in terms of the end product. This product is not an end in itself, and must satisfy clinical and commercial requirements which can be optimized, if at all, with difficulty.The more significant components of a total system, from formulation of the preparation to be freeze-dried and the choice of containers, to prefreezing and the layout and control of the freeze-drying system, are briefly reviewed against the need for a product which is therapeutically satisfactory and free from contamination by microorganisms and submicron particles. Mention is also made of a few special systems. Elsevier Journal Backfiles on ScienceDirect 1907 - 2002 Rowe, T.W.G. oth in Cryobiology Amsterdam : Elsevier 8(1971), 2, Seite 153-172 (DE-627)NLEJ176926798 (DE-600)1463192-1 0011-2240 nnns volume:8 year:1971 number:2 pages:153-172 http://dx.doi.org/10.1016/0011-2240(71)90023-X GBV_USEFLAG_H ZDB-1-SDJ GBV_NL_ARTICLE AR 8 1971 2 153-172 |
language |
English |
source |
in Cryobiology 8(1971), 2, Seite 153-172 volume:8 year:1971 number:2 pages:153-172 |
sourceStr |
in Cryobiology 8(1971), 2, Seite 153-172 volume:8 year:1971 number:2 pages:153-172 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
isfreeaccess_bool |
false |
container_title |
Cryobiology |
authorswithroles_txt_mv |
Rowe, T.W.G. @@oth@@ |
publishDateDaySort_date |
1971-01-01T00:00:00Z |
hierarchy_top_id |
NLEJ176926798 |
id |
NLEJ183053796 |
language_de |
englisch |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ183053796</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20210706192703.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">070505s1971 xx |||||o 00| ||eng c</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ183053796</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)GBVNLZ183053796</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Machinery and methods in freeze-drying</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1971</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The author assumes familiarity with literature on the freeze-drying of biologicals to which he provides a critical supplement. Freeze-drying should be conceived as part of a total system and in terms of the end product. This product is not an end in itself, and must satisfy clinical and commercial requirements which can be optimized, if at all, with difficulty.The more significant components of a total system, from formulation of the preparation to be freeze-dried and the choice of containers, to prefreezing and the layout and control of the freeze-drying system, are briefly reviewed against the need for a product which is therapeutically satisfactory and free from contamination by microorganisms and submicron particles. Mention is also made of a few special systems.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="f">Elsevier Journal Backfiles on ScienceDirect 1907 - 2002</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rowe, T.W.G.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">in</subfield><subfield code="t">Cryobiology</subfield><subfield code="d">Amsterdam : Elsevier</subfield><subfield code="g">8(1971), 2, Seite 153-172</subfield><subfield code="w">(DE-627)NLEJ176926798</subfield><subfield code="w">(DE-600)1463192-1</subfield><subfield code="x">0011-2240</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:8</subfield><subfield code="g">year:1971</subfield><subfield code="g">number:2</subfield><subfield code="g">pages:153-172</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://dx.doi.org/10.1016/0011-2240(71)90023-X</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_H</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-SDJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">8</subfield><subfield code="j">1971</subfield><subfield code="e">2</subfield><subfield code="h">153-172</subfield></datafield></record></collection>
|
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ183053796</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20210706192703.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">070505s1971 xx |||||o 00| ||eng c</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ183053796</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)GBVNLZ183053796</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Machinery and methods in freeze-drying</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1971</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The author assumes familiarity with literature on the freeze-drying of biologicals to which he provides a critical supplement. Freeze-drying should be conceived as part of a total system and in terms of the end product. This product is not an end in itself, and must satisfy clinical and commercial requirements which can be optimized, if at all, with difficulty.The more significant components of a total system, from formulation of the preparation to be freeze-dried and the choice of containers, to prefreezing and the layout and control of the freeze-drying system, are briefly reviewed against the need for a product which is therapeutically satisfactory and free from contamination by microorganisms and submicron particles. Mention is also made of a few special systems.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="f">Elsevier Journal Backfiles on ScienceDirect 1907 - 2002</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rowe, T.W.G.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">in</subfield><subfield code="t">Cryobiology</subfield><subfield code="d">Amsterdam : Elsevier</subfield><subfield code="g">8(1971), 2, Seite 153-172</subfield><subfield code="w">(DE-627)NLEJ176926798</subfield><subfield code="w">(DE-600)1463192-1</subfield><subfield code="x">0011-2240</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:8</subfield><subfield code="g">year:1971</subfield><subfield code="g">number:2</subfield><subfield code="g">pages:153-172</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://dx.doi.org/10.1016/0011-2240(71)90023-X</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_H</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-SDJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">8</subfield><subfield code="j">1971</subfield><subfield code="e">2</subfield><subfield code="h">153-172</subfield></datafield></record></collection>
|
series2 |
Elsevier Journal Backfiles on ScienceDirect 1907 - 2002 |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)NLEJ176926798 |
format |
electronic Article |
delete_txt_mv |
keep |
collection |
NL |
remote_str |
true |
illustrated |
Not Illustrated |
issn |
0011-2240 |
topic_title |
Machinery and methods in freeze-drying |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
t r tr |
hierarchy_parent_title |
Cryobiology |
hierarchy_parent_id |
NLEJ176926798 |
hierarchy_top_title |
Cryobiology |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)NLEJ176926798 (DE-600)1463192-1 |
title |
Machinery and methods in freeze-drying |
spellingShingle |
Machinery and methods in freeze-drying |
ctrlnum |
(DE-627)NLEJ183053796 (DE-599)GBVNLZ183053796 |
title_full |
Machinery and methods in freeze-drying |
journal |
Cryobiology |
journalStr |
Cryobiology |
lang_code |
eng |
isOA_bool |
false |
recordtype |
marc |
publishDateSort |
1971 |
contenttype_str_mv |
zzz |
container_start_page |
153 |
container_volume |
8 |
format_se |
Elektronische Aufsätze |
title_sort |
machinery and methods in freeze-drying |
title_auth |
Machinery and methods in freeze-drying |
abstract |
The author assumes familiarity with literature on the freeze-drying of biologicals to which he provides a critical supplement. Freeze-drying should be conceived as part of a total system and in terms of the end product. This product is not an end in itself, and must satisfy clinical and commercial requirements which can be optimized, if at all, with difficulty.The more significant components of a total system, from formulation of the preparation to be freeze-dried and the choice of containers, to prefreezing and the layout and control of the freeze-drying system, are briefly reviewed against the need for a product which is therapeutically satisfactory and free from contamination by microorganisms and submicron particles. Mention is also made of a few special systems. |
abstractGer |
The author assumes familiarity with literature on the freeze-drying of biologicals to which he provides a critical supplement. Freeze-drying should be conceived as part of a total system and in terms of the end product. This product is not an end in itself, and must satisfy clinical and commercial requirements which can be optimized, if at all, with difficulty.The more significant components of a total system, from formulation of the preparation to be freeze-dried and the choice of containers, to prefreezing and the layout and control of the freeze-drying system, are briefly reviewed against the need for a product which is therapeutically satisfactory and free from contamination by microorganisms and submicron particles. Mention is also made of a few special systems. |
abstract_unstemmed |
The author assumes familiarity with literature on the freeze-drying of biologicals to which he provides a critical supplement. Freeze-drying should be conceived as part of a total system and in terms of the end product. This product is not an end in itself, and must satisfy clinical and commercial requirements which can be optimized, if at all, with difficulty.The more significant components of a total system, from formulation of the preparation to be freeze-dried and the choice of containers, to prefreezing and the layout and control of the freeze-drying system, are briefly reviewed against the need for a product which is therapeutically satisfactory and free from contamination by microorganisms and submicron particles. Mention is also made of a few special systems. |
collection_details |
GBV_USEFLAG_H ZDB-1-SDJ GBV_NL_ARTICLE |
container_issue |
2 |
title_short |
Machinery and methods in freeze-drying |
url |
http://dx.doi.org/10.1016/0011-2240(71)90023-X |
remote_bool |
true |
author2 |
Rowe, T.W.G. |
author2Str |
Rowe, T.W.G. |
ppnlink |
NLEJ176926798 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth |
up_date |
2024-07-06T10:23:10.679Z |
_version_ |
1803824807992623104 |
score |
7.402237 |